Skip to main content

Scholarship opportunity for those who are legally blind

Letty sent this along to me today. I'm just posting it here to share with anyone interested.


We are receiving applications for our 2009 Scholarship and Career Awards. Please share the following information with anyone you know who may be eligible.
Five scholarships are awarded across three categories: College-Bound, Undergraduate and Graduate. The criteria for eligibility are that applicants:

- Must be legally blind (i.e., have a best corrected visual acuity of 20/200 or less in the better eye, and/or a visual field of less than 20 degrees in the better eye).

- Must be US citizens, and reside and attend an accredited school in any of the following states: CT, DE, FL, GA, MA, MD, ME, NC, NH, NJ NY, PA, RI, SC, VA, WV and VT, or Washington, DC. Proof of citizenship will be required of all winners.
Scholarships are based on academic and personal achievements, and candidates are not required to demonstrate financial need.

Previous winners (in any category) of Lighthouse Scholarships, current Lighthouse employees and members of their immediate families are ineligible.

To learn more about the Lighthouse Scholarship and Career Awards program and to download an application, please visit our web site at http://www.lighthouse.org/sca.

The 2009 application deadline is Sunday, March 1, 2009 by 11:59pm. The application and all requested documentation must be submitted via email at sca@lighthouse.org.

If you have any questions regarding the Scholarship and Career Awards program, please email us at sca@lighthouse.org.

Thank you for your help with promoting our Scholarship and Career Awards program.
Rowena Saunders, MSOL
Vice President for Volunteer Resources
Lighthouse International
111 East 59th Street, 8th Floor
New York, NY 10022
Office: 212-821-9405
Fax: 212-821-9687
Mobile: 347-573-3752
Email: RSaunders@Lighthouse.org
Labels:

Comments

Post a Comment

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for
1 comment
Read more

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.
Post a Comment
Read more

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria
Post a Comment
Read more